NASDAQ : RYTM
Rhythm Pharmaceuticals, Inc. — Financial statements
Healthcare · Biotechnology · United States
Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports
Financial statements
Rhythm Pharmaceuticals, Inc. (RYTM) reported revenue of 239.92M USD (TTM). Five years of income statement, balance sheet, cash flow and ratios below.
Income statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Revenue | 239.92M | 189.76M | 130.13M | 77.43M | 23.64M | 3.15M |
| Cost of Revenue | 26.39M | 19.49M | 13.37M | 9.30M | 2.13M | 599.00K |
| Gross Profit | 213.53M | 170.26M | 116.76M | 68.13M | 21.50M | 2.56M |
| Selling, General & Admin | 240.95M | 194.94M | 144.30M | 117.53M | 92.03M | 68.49M |
| Research & Development | 173.21M | 167.34M | 145.56M | 134.95M | 108.63M | 104.13M |
| Operating Expenses | 414.16M | 362.28M | 289.86M | 252.48M | 200.66M | 172.61M |
| Operating Income | -200.63M | -192.02M | -173.10M | -184.36M | -179.16M | -170.06M |
| Interest Expense | -18.48M | -20.58M | -20.60M | -13.89M | -5.20M | |
| Interest & Investment Income | 15.19M | 15.29M | 14.71M | 13.95M | 4.03M | 447.00K |
| Other Non Operating Income (Expenses) | -2.35M | 1.26M | 2.24M | 190.00K | 250.00K | 100.00M |
| EBT Excluding Unusual Items | -204.28M | -196.04M | -176.76M | -184.11M | -180.08M | -69.61M |
| Gain (Loss) on Sale of Investments | -1.04M | |||||
| Other Unusual Items | 8.90M | |||||
| Pretax Income | -204.28M | -196.04M | -260.26M | -184.11M | -181.12M | -69.61M |
| Income Tax Expense | 1.07M | 497.00K | 346.00K | 564.00K | ||
| Net Income | -205.35M | -196.54M | -260.60M | -184.68M | -181.12M | -69.61M |
| Preferred Dividends & Other Adjustments | 4.88M | 5.38M | 3.97M | |||
| Net Income to Common | -210.22M | -201.92M | -264.57M | -184.68M | -181.12M | -69.61M |
| Shares Outstanding (Basic) | 67.44M | 64.98M | 61.00M | 57.67M | 52.12M | 49.60M |
| Shares Outstanding (Diluted) | 67.44M | 64.98M | 61.00M | 57.67M | 52.12M | 49.60M |
| EPS (Basic) | -3.12 | -3.11 | -4.34 | -3.20 | -3.47 | -1.40 |
| EPS (Diluted) | -3.12 | -3.11 | -4.34 | -3.20 | -3.47 | -1.40 |
| Free Cash Flow | -106.30M | -116.63M | -113.88M | -136.20M | -173.71M | -146.44M |
| Free Cash Flow Per Share | -1.58 | -1.79 | -1.87 | -2.36 | -3.33 | -2.95 |
| Gross Margin | 89.00% | 89.73% | 89.73% | 87.99% | 90.98% | 81.01% |
| Operating Margin | -83.62% | -101.19% | -133.03% | -238.10% | -757.92% | -5,391.85% |
| Profit Margin | -87.62% | -106.41% | -203.32% | -238.52% | -766.22% | -2,207.10% |
| Free Cash Flow Margin | -44.31% | -61.46% | -87.51% | -175.91% | -734.87% | -4,642.90% |
| EBITDA | -199.55M | -190.68M | -171.54M | -182.60M | -177.49M | -168.90M |
| EBITDA Margin | -83.17% | -100.48% | -131.83% | -235.83% | ||
| D&A For EBITDA | 1.08M | 1.34M | 1.56M | 1.76M | 1.67M | 1.16M |
| EBIT | -200.63M | -192.02M | -173.10M | -184.36M | -179.16M | -170.06M |
| EBIT Margin | -83.62% | -101.19% | -133.03% | -238.10% | ||
| Revenue as Reported | 239.92M | 189.76M | 130.13M | 77.43M | 23.64M | 3.15M |
Balance sheet
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Cash & Equivalents | 65.61M | 54.30M | 89.14M | 60.08M | 127.68M | 59.25M |
| Short-Term Investments | 265.28M | 334.65M | 231.43M | 215.76M | 205.61M | 235.61M |
| Cash & Short-Term Investments | 330.90M | 388.95M | 320.56M | 275.85M | 333.29M | 294.86M |
| Receivables | 40.41M | 26.08M | 18.51M | 14.87M | 6.22M | 1.02M |
| Inventory | 30.52M | 25.75M | 18.74M | 8.62M | 2.92M | 111.00K |
| Other Current Assets | 26.13M | 16.38M | 8.93M | 11.81M | 12.40M | |
| Total Current Assets | 426.56M | 466.92M | 374.20M | 308.27M | 354.24M | 308.39M |
| Property, Plant & Equipment | 2.92M | 4.15M | 4.11M | 2.12M | 3.38M | 4.33M |
| Other Intangible Assets | 4.89M | 5.32M | 6.17M | 7.03M | 7.88M | 4.66M |
| Long-Term Deferred Charges | 1.66M | 6.21M | 12.59M | |||
| Other Long-Term Assets | 2.89M | 2.15M | 1.58M | 2.73M | 16.98M | 12.14M |
| Total Assets | 437.27M | 480.20M | 392.27M | 332.75M | 382.48M | 329.52M |
| Accounts Payable | 16.16M | 13.95M | 12.33M | 4.88M | 4.80M | 5.74M |
| Accrued Expenses | 86.70M | 79.78M | 58.31M | 42.85M | 30.48M | 29.26M |
| Current Portion of Long-Term Debt | 12.70M | 7.30M | 1.54M | |||
| Current Portion of Leases | 703.00K | 650.00K | 770.00K | 684.00K | 606.00K | |
| Current Unearned Revenue | 194.00K | 1.29M | 1.29M | 1.43M | 7.00M | |
| Other Current Liabilities | 7.31M | 4.08M | 42.05M | 5.41M | 2.42M | 826.00K |
| Total Current Liabilities | 123.59M | 105.94M | 115.52M | 55.20M | 39.81M | 43.43M |
| Long-Term Debt | 93.40M | 100.89M | 108.27M | 106.14M | 75.81M | |
| Long-Term Leases | 2.98M | 3.34M | 3.94M | 490.00K | 1.26M | 1.95M |
| Other Long-Term Liabilities | 1.15M | 1.34M | ||||
| Total Liabilities | 219.97M | 210.17M | 227.72M | 162.99M | 118.22M | 45.37M |
| Common Stock | 69.00K | 67.00K | 61.00K | 59.00K | 56.00K | 50.00K |
| Additional Paid-In Capital | 1.56B | 1.49B | 1.18B | 1.06B | 974.36M | 813.04M |
| Retained Earnings | -1.46B | -1.35B | -1.16B | -894.74M | -710.06M | -528.94M |
| Comprehensive Income & Other | -912.00K | -796.00K | -39.00K | 134.00K | -92.00K | -1.00K |
| Total Common Equity | 102.98M | 139.07M | 21.73M | 169.76M | 264.26M | 284.15M |
| Shareholders' Equity | 217.30M | 270.03M | 164.55M | 169.76M | 264.26M | 284.15M |
| Total Liabilities & Equity | 437.27M | 480.20M | 392.27M | 332.75M | 382.48M | 329.52M |
| Total Debt | 109.78M | 112.17M | 113.75M | 107.40M | 77.75M | 2.55M |
| Net Cash (Debt) | 221.11M | 276.77M | 206.82M | 168.44M | 255.53M | 292.30M |
| Net Cash Per Share | 3.28 | 4.26 | 3.39 | 2.92 | 4.90 | 5.89 |
| Filing Date Shares Outstanding | 68.85M | 68.29M | 63.22M | 60.14M | 56.75M | 50.33M |
| Total Common Shares Outstanding | 68.82M | 67.21M | 62.39M | 59.43M | 56.61M | 50.28M |
| Working Capital | 302.98M | 360.97M | 258.68M | 253.06M | 314.43M | 264.96M |
| Book Value Per Share | 1.50 | 2.07 | 0.35 | 2.86 | 4.67 | 5.65 |
| Tangible Book Value | 98.09M | 133.75M | 15.55M | 162.73M | 256.38M | 279.49M |
| Tangible Book Value Per Share | 1.43 | 1.99 | 0.25 | 2.74 | 4.53 | 5.56 |
| Machinery | 2.69M | 2.69M | 2.69M | 2.65M | 2.37M | |
| Construction In Progress | 926.00K | |||||
| Leasehold Improvements | 2.73M | 2.71M | 2.71M | 2.71M | 2.71M |
Cash flow statement
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Net Income | -205.35M | -196.54M | -260.60M | -184.68M | -181.12M | -69.61M |
| Depreciation & Amortization | 1.08M | 1.34M | 1.56M | 1.76M | 1.67M | 1.16M |
| Loss (Gain) From Sale of Investments | -6.16M | -6.52M | -8.16M | -9.84M | -1.27M | |
| Stock-Based Compensation | 87.23M | 66.82M | 39.68M | 32.55M | 19.83M | 20.80M |
| Other Operating Activities | 21.79M | 20.19M | 103.07M | 19.24M | 4.87M | -100.25M |
| Change in Accounts Receivable | -14.75M | -7.57M | -3.65M | -8.64M | -5.20M | -1.25M |
| Change in Inventory | -12.81M | -7.47M | -10.12M | -5.71M | -2.81M | -11.00K |
| Change in Accounts Payable | 23.11M | 21.89M | 21.92M | 14.77M | 1.54M | 18.31M |
| Change in Unearned Revenue | -1.09M | -148.00K | -6.61M | |||
| Change in Other Net Operating Assets | 507.00K | -6.72M | 2.42M | 4.53M | -4.34M | -15.15M |
| Operating Cash Flow | -105.35M | -115.67M | -113.88M | -136.16M | -173.43M | -146.00M |
| Capital Expenditures | -953.00K | -953.00K | -47.00K | -281.00K | -434.00K | |
| Sale (Purchase) of Intangibles | -40.00M | -40.00M | -40.50M | -5.67M | 7.00M | |
| Investment in Securities | -103.98M | -96.20M | -7.67M | 49.00K | 32.31M | -163.72M |
| Other Investing Activities | -4.00M | 95.00M | ||||
| Investing Cash Flow | -144.94M | -137.15M | -48.17M | -5.67M | 28.03M | -62.16M |
| Issuance of Common Stock | 211.67M | 237.88M | 56.39M | 57.40M | 141.49M | 166.48M |
| Other Financing Activities | -22.16M | -19.92M | -4.00M | 16.97M | 72.34M | |
| Financing Cash Flow | 179.79M | 217.96M | 191.24M | 74.37M | 213.83M | 166.48M |
| Foreign Exchange Rate Adjustments | 599.00K | 87.00K | 2.00K | -142.00K | ||
| Net Cash Flow | -69.90M | -34.78M | 29.19M | -67.60M | 68.43M | -41.68M |
| Free Cash Flow | -106.30M | -116.63M | -113.88M | -136.20M | -173.71M | -146.44M |
| Free Cash Flow Margin | -44.31% | -61.46% | -87.51% | -175.91% | -734.87% | -4,642.90% |
| Free Cash Flow Per Share | -1.58 | -1.79 | -1.87 | -2.36 | -3.33 | -2.95 |
| Levered Free Cash Flow | -130.59M | -145.98M | -81.99M | -91.47M | -105.11M | -57.05M |
| Unlevered Free Cash Flow | -119.04M | -133.12M | -69.11M | -82.79M | -101.86M | -57.05M |
| Change in Working Capital | -3.94M | -968.00K | 10.57M | 4.81M | -17.41M | 1.90M |
Ratios
Fiscal year January - December; amounts in USD.
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | |
|---|---|---|---|---|---|---|
| Market Capitalization | 6.37B | 7.14B | 3.44B | 2.72B | 1.64B | 501.68M |
| Enterprise Value | 6.15B | 6.99B | 3.40B | 2.42B | 1.30B | 176.02M |
| Last Close Price | 92.57 | 107.04 | 55.98 | 45.97 | 29.12 | 9.98 |
| PS Ratio | 26.57 | 37.65 | 26.44 | 35.09 | 69.42 | 159.06 |
| PB Ratio | 61.86 | 26.45 | 20.91 | 16.00 | 6.21 | 1.77 |
| P/TBV Ratio | 64.98 | 53.41 | 221.17 | 16.69 | 6.40 | 1.79 |
| EV/Sales Ratio | 25.64 | 36.82 | 26.10 | 31.24 | 54.79 | 55.81 |
| Debt / Equity Ratio | 0.51 | 0.41 | 0.69 | 0.63 | 0.29 | 0.01 |
| Net Debt / Equity Ratio | -1.02 | -1.02 | -1.26 | -0.99 | -0.97 | -1.03 |
| Net Debt / EBITDA Ratio | 1.11 | 1.45 | 1.21 | 0.92 | 1.44 | 1.73 |
| Net Debt / FCF Ratio | 2.08 | 2.37 | 1.82 | 1.24 | 1.47 | 2.00 |
| Asset Turnover | 0.59 | 0.43 | 0.36 | 0.22 | 0.07 | 0.01 |
| Inventory Turnover | 1.07 | 0.88 | 0.98 | 1.61 | 1.41 | |
| Quick Ratio | 3.00 | 3.92 | 2.94 | 5.27 | 8.53 | 6.81 |
| Current Ratio | 3.45 | 4.41 | 3.24 | 5.58 | 8.90 | 7.10 |
| Return on Equity (ROE) | -117.05% | -90.45% | -155.91% | -85.10% | -66.05% | -30.89% |
| Return on Assets (ROA) | -30.96% | -27.51% | -29.84% | -32.22% | -31.45% | -41.15% |
| Return on Capital Employed (ROCE) | -64.00% | -51.30% | -62.50% | -66.40% | -52.30% | -59.40% |
| Earnings Yield | -3.37% | -2.75% | -7.58% | -6.80% | -11.04% | -13.88% |
| FCF Yield | -1.67% | -1.63% | -3.31% | -5.01% | -10.59% | -29.19% |
| Buyback Yield / Dilution | -8.09% | -6.54% | -5.76% | -10.65% | -5.08% | -12.40% |